Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Alvir

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Psychopharmacology Bulletin|January 1, 1991
Premenstrual and menstrual symptom clusters and response to calcium treatmentJ M Alvir, S Thys-Jacobs
The Journal of Clinical Psychiatry|September 1, 1994
Agranulocytosis: incidence and risk factorsJ M Alvir, J A Lieberman
Psychopharmacology Bulletin|January 1, 1995
Comparative analysis of three PMS assessment instruments--the identification of premenstrual syndrome with core symptomsS Thys-Jacobs, J M Alvir, P Fratarcangelo
Psychopharmacology Bulletin|January 1, 1995
Do white-cell count spikes predict agranulocytosis in clozapine recipients?J M Alvir, J A Lieberman, A Z Safferman
Psychopharmacology Bulletin|January 1, 1990
A single estimate of separate within-individual correlations: applications in psychopharmacologyJ M Alvir, J A Lieberman, M T Borenstein
Psychopharmacology Bulletin|January 1, 1990
Behavioral response to methylphenidate and treatment outcome in first episode schizophreniaD Jody, J A Lieberman, S Geisler, et al.
Schizophrenia Research|January 19, 2000
Obstetric complications in schizophrenia, schizoaffective disorder and normal comparison subjectsH Gunduz, M G Woerner, J M Alvir, et al.
The American Journal of Clinical Nutrition|August 1, 1988
The National WIC Evaluation: evaluation of the Special Supplemental Food Program for Women, Infants, and Children. II. Review of past studies of WICD Rush, J Leighton, N L Sloan, et al.
Psychological Medicine|July 15, 1999
Obstetric complications predict treatment response in first-episode schizophreniaJ M Alvir, M G Woerner, H Gunduz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1992
Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuseS G Siris, P C Bermanzohn, S E Mason, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Psychopharmacology Bulletin|January 1, 1991
Premenstrual and menstrual symptom clusters and response to calcium treatmentJ M Alvir, S Thys-Jacobs
The Journal of Clinical Psychiatry|September 1, 1994
Agranulocytosis: incidence and risk factorsJ M Alvir, J A Lieberman
Psychopharmacology Bulletin|January 1, 1995
Comparative analysis of three PMS assessment instruments--the identification of premenstrual syndrome with core symptomsS Thys-Jacobs, J M Alvir, P Fratarcangelo
Psychopharmacology Bulletin|January 1, 1995
Do white-cell count spikes predict agranulocytosis in clozapine recipients?J M Alvir, J A Lieberman, A Z Safferman
Psychopharmacology Bulletin|January 1, 1990
A single estimate of separate within-individual correlations: applications in psychopharmacologyJ M Alvir, J A Lieberman, M T Borenstein
Psychopharmacology Bulletin|January 1, 1990
Behavioral response to methylphenidate and treatment outcome in first episode schizophreniaD Jody, J A Lieberman, S Geisler, et al.
Schizophrenia Research|January 19, 2000
Obstetric complications in schizophrenia, schizoaffective disorder and normal comparison subjectsH Gunduz, M G Woerner, J M Alvir, et al.
The American Journal of Clinical Nutrition|August 1, 1988
The National WIC Evaluation: evaluation of the Special Supplemental Food Program for Women, Infants, and Children. II. Review of past studies of WICD Rush, J Leighton, N L Sloan, et al.
Psychological Medicine|July 15, 1999
Obstetric complications predict treatment response in first-episode schizophreniaJ M Alvir, M G Woerner, H Gunduz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1992
Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuseS G Siris, P C Bermanzohn, S E Mason, et al.
Pageof 5